Condition or Therapy: Autism spectrum disorder
Category: Psychiatry and Behavioral Medicine

What is the goal of this study?

The Autism Biomarkers Consortium for Clinical Trials (ABC-CT) is seeking families to participate in a study to improve diagnosis and treatment in autism spectrum disorder (ASD).

Who can join the study?

We are currently recruiting both typically developing children and children with a diagnosis of ASD between the ages of 6 and 11 years old.

What happens in the study?

Using EEG to measure brain function, eye tracking technology to measure visual attention, and automated recording techniques to assess behavior and speech, children will be monitored over a six-month period. In addition to the behavioral measures and biomarker data, this community resource will also include DNA samples from children with ASD and their parents for use in future genetic studies.

Who can I contact for information or to enroll?

Email the research coordinator.


Study Location(s): Seattle Children's Autism Center, University of Washington
Principal Investigator: Dr. Raphael Bernier